Cargando…
Tumor-associated myeloid cells in cancer immunotherapy
Tumor-associated myeloid cells (TAMCs) are among the most important immune cell populations in the tumor microenvironment, and play a significant role on the efficacy of immune checkpoint blockade. Understanding the origin of TAMCs was found to be the essential to determining their functional hetero...
Autores principales: | Cheng, Xinyu, Wang, Huilan, Wang, Zhongyu, Zhu, Bo, Long, Haixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324139/ https://www.ncbi.nlm.nih.gov/pubmed/37415162 http://dx.doi.org/10.1186/s13045-023-01473-x |
Ejemplares similares
-
Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy
por: Zeng, Xianghua, et al.
Publicado: (2020) -
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
por: Wang, Yi, et al.
Publicado: (2022) -
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021) -
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
por: Yuan, Ting, et al.
Publicado: (2023) -
Myeloid-derived cells are key targets of tumor immunotherapy
por: Medina-Echeverz, José, et al.
Publicado: (2014)